Evolysse™
Evolysse™ in Lake Forest
Achieve smooth, youthful skin with Evolysse™ at Ciao Bella Aesthetics, a leading med spa in Lake Forest. Evolysse Smooth and Evolysse Form soften wrinkles that form in dynamic areas of the face, such as the nasolabial folds performed by Cellea Belotti, RN, BSN, a highly-experienced aesthetic nurse injector, provides a refreshed and rejuvenated look without compromising your natural expressions.
Evolysse™ Benefits
Evolysse™ is a next-generation dermal filler line developed by Evolus in partnership with Symatese, featuring two FDA-approved hyaluronic acid (HA) gels: Evolysse™ Form and Evolysse™ Smooth.
- Advanced Cold-X™ Technology
- Natural Movement and Flexibility
- Long-Lasting Results
- High Patient Satisfaction
- FDA-Approved Safety and Efficacy
The First Advanced Injectable Hyaluronic Acid Technology Launched in a Decade
Evolysse™ is the next-generation injectable hyaluronic acid made with Cold-X™ Technology. Evolysse Smooth and Evolysse Form soften wrinkles that form in dynamic areas of the face, such as the nasolabial folds.
Cold-X Technology: Temperature Matters
Preserve
Cold-X Technology uses near-freezing temperatures aimed at preserving the natural structure of the HA molecule.
Perform
This results in a gel with desirable viscoelastic properties that performs in the treatment area and is designed to feel natural in the facial tissues.
Designed to Achieve a Range of Treatment Goals for Dynamic Facial Wrinkles or Folds
Evolysse Form
Treatment goal:
Lift & support
Evolysse Smooth Treatment goal:
Soften & smooth
Lift & support
Evolysse Smooth Treatment goal:
Soften & smooth
Safety Is Cool
In the head-to-head clinical study vs Restylane-L, there were no delayed onset nodules with Evolysse Form or Evolysse Smooth.
The most common side effects were temporary and at the injection site, such as tenderness, swelling, bruising, pain, redness, and lumps. Most common treatment responses were mild or moderate and resolved within 1 week. All treatment-emergent adverse events were mild to moderate in severity.
The most common side effects were temporary and at the injection site, such as tenderness, swelling, bruising, pain, redness, and lumps. Most common treatment responses were mild or moderate and resolved within 1 week. All treatment-emergent adverse events were mild to moderate in severity.
